CYP2J2(∗)7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

Chemotherapy-induced hematologic toxicity is the primary reasons of dose reductions and/or delays, low relative dose intensity (RDI), and predicts anticancer response. We investigated the incidence and predictors of chemotherapy-induced hematologic toxicities and reduced RDI in Ethiopian breast canc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Pharmacol
Glavni autori: Ahmed, Jemal Hussien, Makonnen, Eyasu, Yimer, Getnet, Seifu, Daniel, Bekele, Abebe, Assefa, Mathewos, Aseffa, Abraham, Howe, Rawleigh, Fotoohi, Alan, Hassan, Moustapha, Aklillu, Eleni
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527746/
https://ncbi.nlm.nih.gov/pubmed/31139078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00481
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items